Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Peripheral T-cell lymphoma, not otherwise specified: a retrospective single-center analysis].
Suzuki T, Kawamoto K, Tamura S, Uemura S, Kaihatsu A, Nemoto H, Kobayashi H, Ushiki T, Fuse K, Shibazaki Y, Moriyama M, Masuko M, Narita M, Sone H, Aoki S, Nakamura N, Oshima K, Takizawa J. Suzuki T, et al. Among authors: masuko m. Rinsho Ketsueki. 2017;58(8):905-911. doi: 10.11406/rinketsu.58.905. Rinsho Ketsueki. 2017. PMID: 28883272 Japanese.
Female-to-male allogeneic transplantation affects outcomes differently according to the type of haplo-transplantation.
Tamaki M, Kawamura S, Takano K, Nakamae H, Doki N, Ohigashi H, Maruyama Y, Ota S, Hiramoto N, Eto T, Yoshihara S, Matsuoka KI, Masuko M, Onizuka M, Kanda Y, Fukuda T, Atsuta Y, Yanagisawa R, Yakushijin K, Nakasone H. Tamaki M, et al. Among authors: masuko m. Cytotherapy. 2025 Feb;27(2):213-221. doi: 10.1016/j.jcyt.2024.09.007. Epub 2024 Oct 5. Cytotherapy. 2025. PMID: 39453336
Pharmacokinetic and pharmacodynamic analysis of cyclosporine A (CsA) to find the best single time point for the monitoring and adjusting of CsA dose using twice-daily 3-h intravenous infusions in allogeneic hematopoietic stem cell transplantation.
Furukawa T, Kurasaki-Ida T, Masuko M, Tsukada N, Okazuka K, Sato N, Yano T, Abe T, Momoi A, Shibasaki Y, Higashimura M, Karimata K, Moriyama M, Kuroha T, Takizawa J, Toba K, Narita M, Fuse I, Takahashi M, Aizawa Y. Furukawa T, et al. Among authors: masuko m. Int J Hematol. 2010 Jul;92(1):144-51. doi: 10.1007/s12185-010-0610-0. Epub 2010 Jun 9. Int J Hematol. 2010. PMID: 20533008 Clinical Trial.
Clinical value of assessing the response to imatinib monitored by interphase FISH and RQ-PCR for BCR-ABL in peripheral blood for long-term survival of chronic phase CML patients: results of the Niigata CML-multi-institutional co-operative clinical study.
Furukawa T, Narita M, Koike T, Takai K, Nagai K, Kobayashi M, Koyama S, Seki Y, Takahashi H, Fujiwara M, Kishi K, Nikkuni K, Isahai N, Higuchi W, Nomoto N, Maruyama S, Masuko M, Kuroha T, Abe T, Toba K, Takahashi M, Aizawa Y, Shibata A. Furukawa T, et al. Among authors: masuko m. Int J Hematol. 2011 Mar;93(3):336-343. doi: 10.1007/s12185-011-0774-2. Epub 2011 Feb 5. Int J Hematol. 2011. PMID: 21293953 Clinical Trial.
130 results